Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Chewy vs. Five Below: Which Retailer Stock Is a Better Buy for 2027?

Chewy's recurring revenue model and high margins clash with Five Below's explosive growth and valuation appeal, here's which edge matters more for your 2027 portfolio.

Both Chewy Inc. (CHWY) and Five Below Inc. (FIVE) are competing to capture a share of discretionary spending, but their operational approaches differ significantly. Chewy specializes in e-commerce for pet owners, while Five Below is a physical retail chain selling low-cost items for kids, pre-teens, and teens.

Chewy reported a revenue of approximately $12.6 billion in FY 2025, a 6.2% increase year-over-year. The company generates recurring revenue through its Autoship subscription program and high-margin services like pharmacy and telehealth. Its net margin was around 1.8% as of the end of the 2025 fiscal year. Chewy's debt-to-equity ratio is approximately 1.0, meaning its total debt equals shareholder equity. The company's current ratio is about 0.9, indicating its ability to cover short-term liabilities with short-term assets.

On the other hand, Five Below reported sales of about $4.8 billion in FY 2025, which grew by nearly 23% year-over-year. The company generated a net income of $358.6 million during this period, resulting in a net margin of roughly 7.5%. The company's debt-to-equity ratio is approximately 0.9, and its current ratio stands at about 2.0, reflecting a strong ability to meet immediate financial obligations. Five Below's free cash flow for fiscal 2025 was close to $411.7 million.

Valuation metrics suggest that Five Below may offer a more attractive entry point based on future earnings estimates, while Chewy presents a lower entry point based on sales volume. As Chewy expands its Autoship program and explores high-growth areas like veterinarian and general pet health services, it faces competition from brick-and-mortar retailers like PetSmart and Petco. Meanwhile, Five Below relies on rapid store growth and effective distribution to navigate international trade policies and inventory-related risks.

Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Also reported by 1 other outlet

Read the original at fool.com →

More in Health & Medicine

More from Monday 2 November →